Generation of an induced pluripotent stem cell line (SJTUGHi003-A) from a patient with Sorsby fundus dystrophy carrying c.484G>A mutation in TIMP3 gene

Xinyue Zhu,Lu Tang,Ting Zhang,Xinyue Bai,Jieqiong Chen,Lei Zhang,Yuanyuan Gong,Mei Jiang,Xiaodong Sun

DOI: https://doi.org/10.1016/j.scr.2024.103423

IF: 1.587

2024-04-18

Stem Cell Research

Abstract:Sorsby fundus dystrophy (SFD) is a rare autosomal dominant disorder with macular dystrophy and severe visual loss. Mutations in TIMP3 gene has been related to SFD with mechanisms unclear. We have successfully reprogrammed the peripheral blood mononuclear cells (PBMCs) from an SFD patient carrying c.484G>A mutation in TIMP3 gene to induced pluripotent stem cells (iPSCs) and characterized their pluripotency and genetic stability. This line may serve as a useful tool to explore the role of TIMP3 in SFD pathogenesis.

cell biology,biotechnology & applied microbiology,cell & tissue engineering

What problem does this paper attempt to address?

Establishment of an Induced Pluripotent Stem Cell Line (Zjulli004-A) from a Hypertrophic Cardiomyopathy Patient Carrying MYBPC3/c.3764C>A Mutation

Yaxun Sun,Jingjun Zhou,Hongkun Wang,Hao Wang,Xianzhen Chen,Tingyu Gong,Ping Liang,Chenyang Jiang

DOI: https://doi.org/10.1016/j.scr.2022.102898

IF: 1.587

2022-01-01

Stem Cell Research

Abstract:Hypertrophic cardiomyopathy (HCM) is an inherited cardiovascular disease characterized by left ventricular hypertrophy and a high risk of sudden death. In this study, a skin biopsy was obtained from a HCM patient harboring a heterozygous missense mutation (c.3764C>A; p.A1225D) in the myosin binding protein C3 (MYBPC3) gene. The isolated fibroblasts were reprogrammed using non-integrated Sendai viral method to establish the patient-specific induced pluripotent stem cell (iPSC) line. The established iPSC line displayed normal morphology and karyotype, expressed pluripotency markers, and can differentiate into three germ layers in vivo.
Generation of an induced pluripotent stem cell line from a patient carrying FBN1/c.6734 G > A mutation

Ziwei Pan,Hongkun Wang,Hao Wang,Yong Liu,Ping Liang

DOI: https://doi.org/10.1016/j.scr.2021.102459

IF: 1.587

2021-01-01

Stem Cell Research

Abstract:Mutations in FBN1 (gene encodes the matrix protein fibrillin 1), are usually associated with Marfan syndrome (MS). This syndrome contains ocular, skeletal, cardiovascular, pulmonary, cutaneous and neurological abnormalities. Here, we introduced an induced pluripotent stem cell (iPSC) line from a patient who suffered from severe cardiovascular disease and carried a c.6734G > A mutation in FBN1. Dermal fibroblasts of the patient were reprogrammed with non-integrating Sendai virus (SeV). Generated iPSC line exhibited normal karyotype, showed embryonic stem cell-like morphology, expressed pluripotency markers, and was capable of differentiating into three germ layers. This iPSC line will be a valuable tool for studying MS.
Generation of an induced pluripotent stem cell line from a patient carrying FBN1/c.6734 G > A mutation.

Ziwei Pan,Hongkun Wang,Hao Wang,Yong Liu,Ping Liang

DOI: https://doi.org/10.1016/j.scr.2021.102459

IF: 1.587

2021-01-01

Stem Cell Research

Abstract:Mutations in FBN1 (gene encodes the matrix protein fibrillin 1), are usually associated with Marfan syndrome (MS). This syndrome contains ocular, skeletal, cardiovascular, pulmonary, cutaneous and neurological abnormalities. Here, we introduced an induced pluripotent stem cell (iPSC) line from a patient who suffered from severe cardiovascular disease and carried a c.6734G > A mutation in FBN1. Dermal fibroblasts of the patient were reprogrammed with non-integrating Sendai virus (SeV). Generated iPSC line exhibited normal karyotype, showed embryonic stem cell-like morphology, expressed pluripotency markers, and was capable of differentiating into three germ layers. This iPSC line will be a valuable tool for studying MS.
Generation of an Induced Pluripotent Stem Cell Line (Zjulli003-A) from a Hypertrophic Cardiomyopathy Patient Carrying MYH7/c.4384G > A Mutation

Jingjun Zhou,Yaxun Sun,Hongkun Wang,Hao Wang,Fengfeng Guo,Xianzhen Chen,Tingyu Gong,Chenyang Jiang,Ping Liang

DOI: https://doi.org/10.1016/j.scr.2022.102883

IF: 1.587

2022-01-01

Stem Cell Research

Abstract:Hypertrophic cardiomyopathy (HCM) is an autosomal dominant inherited cardiovascular disease characterized by left ventricular hypertrophy and cardiomyocyte disarray. In this study, a skin biopsy was obtained from a HCM patient, who carried a missense mutation (c.4384G > A; p.E1462K) in the myosin heavy chain 7 (MYH7) gene. The skin fibroblasts were subsequently reprogrammed with a non-integrated Sendai viral method to generate a patient-specific induced pluripotent stem cell (iPSC) line. The generated iPSC line showed typical morphology and normal karyotype, expressed pluripotency markers, and was capable to differentiate into three germ layers.
Generation of an Induced Pluripotent Stem Cell Line from a Brugada Syndrome Patient Carrying SCN5A/c.3118G>C Mutation

Hangping Fan,Jun Su,Xiaochen Wang,Hao Wang,Xianzhen Chen,Yaxun Sun,Chenyang Jiang,Ping Liang

DOI: https://doi.org/10.1016/j.scr.2024.103529

IF: 1.587

2024-01-01

Stem Cell Research

Abstract:Brugada syndrome (BrS) is a hereditary arrhythmia syndrome characterized by right bundle branch block on an electrocardiogram and persistent ST-segment elevation in the right precordial leads. In this study, we describe the establishment of an induced pluripotent stem cell (iPSC) line derived from a BrS patient carrying the novel heterogeneous missense mutation (c.3118G>C; p.G1040R) in the sodium channel protein type 5 subunit alpha (SCN5A) gene. Skin fibroblasts underwent reprogramming using a non-integrated Sendai viral method. Generated iPSC line exhibited embryonic stem cell-like morphology, maintained a normal karyotype, expressed pluripotency markers, and demonstrated the capacity to differentiate into three germ layers.
Generation of Induced Pluripotent Stem Cell Line (Zzui0012-A) from a Patient with Fahr's Disease Caused by a Novel Mutation in SLC20A2 Gene.

Qinxian Zhang,Zhuo Li,Huifang Sun,Shoutao Zhang,Jin Zhang,Yanlin Wang,Hui Fang,Yuming Xu

DOI: https://doi.org/10.1016/j.scr.2019.101395

IF: 1.587

2019-01-01

Stem Cell Research

Abstract:Several SLC20A2 mutations have been implicated as potential causes of Fahr's disease, a subtype of primary familial brain calcification (PFBC), but very few patient-derived induced pluripotent stem cell (iPSC) models have been established. We have identified a novel SLC20A2 mutation in a family with Fahr's disease. We subsequently obtained dermal fibroblasts from a patient in this family. These fibroblasts were successfully transformed into iPSCs by employing episomal plasmids expressing OCT3/4, SOX2, KLF4, LIN28, and L-MYC. Our approach offers a resource and a platform for further research into the mechanism of Fahr's disease and could facilitate development and screening of pharmaceutical and gene therapies.
Generation of Induced Pluripotent Stem Cell Line (Zzui007-A) from a 52-Year-old Patient with a Novel CHCHD2 Gene Mutation in Parkinson's Disease.

Yanlin Wang,Zhilei Wang,Huifang Sun,Chengyuan Mao,Jing Yang,Yutao Liu,Han Liu,Shoutao Zhang,Jin Zhang,Yuming Xu,Changhe Shi

DOI: https://doi.org/10.1016/j.scr.2018.08.011

IF: 1.587

2018-01-01

Stem Cell Research

Abstract:CHCHD2 mutation has been reported as a potential cause of a rare form of familial Parkinson's disease. Recently, a novel CHCHD2 mutation was identified in a family with Parkinson's disease. The dermal fibroblasts of the patient were obtained and successfully transformed into induced pluripotent stem cells(iPSCs), employing episomal plasmids expressing OCT3/4, SOX2, KLF4, LIN28, and L-MYC. Our model may offer a good platform for further research on the pathomechanism, drug testing, and gene therapy of this disease.
Generation of an induced pluripotent stem cell line (ZJUi013-A) from a Familial cortical myoclonic tremor with epilepsy type 1 patient carrying (TTTCA)n insertion in the SAMD12 gene

Fan Zhang,Shuqi Chen,Yiling Chen,Xinhui Chen,Zhidong Cen,Wei Luo

DOI: https://doi.org/10.1016/j.scr.2023.103236

IF: 1.587

2023-01-01

Stem Cell Research

Abstract:FCMTE1 is an autosomal dominant inherited neurodegenerative disorder characterized by myoclonic tremors and epilepsy. The cause of FCMTE1 is an abnormal (TTTCA)n insertion in intron 4 of SAMD12 gene. Fibroblasts obtained from a FCMTE1 patient were successfully transformed into induced pluripotent stem cells (iPSCs) (ZJUi013-A) using the Sendai virus. Our approach provided a resource for further pathogenesis study and drug screening of FCMTE1.
Generation of Five Induced Pluripotent Stem Cell Lines with DMD/c.497G > T Mutation from Renal Epithelial Cells of a Duchenne Muscular Dystrophy Patient and a Recessive Carrier Parent

Jun Su,Jue Wang,Long Wang,Tongyu Li,Hongkun Wang,Jiaxi Shen,Hao Wang,Jian Zhang,Weiqiang Lin,Jinyu Huang,Ping Liang

DOI: https://doi.org/10.1016/j.scr.2020.102021

IF: 1.587

2020-01-01

Stem Cell Research

Abstract:Duchenne muscular dystrophy (DMD), an inherited disease caused by the dystrophin gene mutation, is the most common muscular dystrophy in children and is clinically characterized by progressive muscle degeneration and severe cardiomyopathy. In this study, renal epithelial cells were obtained from urine samples of a DMD patient (4 years old) and his recessive carrier parent (35 years old). The cells were reprogrammed with non-integrating Sendai virus to generate three induced pluripotent stem cell (iPSC) clones for the patient and two clones for non-manifesting mutation carrier parent. The iPSC lines had normal karyotypes, iPSC morphology, pluripotency expression markers, and were capable of differentiating into the three germ layers.
Verification of an Ipsc Line (Lzui002-A) from a Patient with a Novel Mutation in the TBL1X Gene.

Yanli Wang,Zengping Liu,Chi Chen,Yong Li,Minxin Guan,Baicheng Xu,Yufen Guo

DOI: https://doi.org/10.1016/j.scr.2022.102761

IF: 1.587

2022-01-01

Stem Cell Research

Abstract:More than 120 genes have been reported to be associated with deafness, and deletion of the TBL1X gene may cause deafness in humans. In this study, we generated an induced pluripotent stem cell (iPSC) line from dermal fibroblasts of a 34-year-old deaf person with a novel variant c.342_343insGCGGCG in the TBL1X gene. The induced patient-specific iPSC line with a normal karyotype and expressed pluripotent markers, it also shows differentiation totipotency and tridermogenesis in vivo. It may be a good model for studying hearing loss in vitro and it will benefit to the development of new therapies for deafness.
Generation of an induced pluripotent stem cell line (SJTUGHi001-A) from a patient with Retinitis Pigmentosa carrying c.77C > T mutation in RAX2 gene

Xinyue Bai,Jieqiong Chen,Xiaohuan Zhao,Xinyue Zhu,Xiaoyan Ding,Ting Zhang,Mei Jiang,Xiaodong Sun

DOI: https://doi.org/10.1016/j.scr.2024.103390

IF: 1.587

2024-03-15

Stem Cell Research

Abstract:Retinitis pigmentosa (RP) is a group of genetically heterogeneous retinopathy resulting in irreversible loss of vision. Mutations in RAX2 gene has been related to RP with mechanisms unclear. Here, we generated a human induced pluripotent stem cell (iPSC) line from peripheral blood mononuclear cells of a RP patient carrying c.77C > T mutation in RAX2 gene. This cell line was induced by integration-free episomal vectors and validated for pluripotency and differentiation capacity, which may serve as a model to study the role of RAX2 in RP pathogenesis.

cell biology,biotechnology & applied microbiology,cell & tissue engineering
Generation of a Human Induced Pluripotent Stem Cell Line from a Female Patient Carrying LZTR1 Gene Mutation

Jinghua Ruan,Mengqing Wu,Jiakai Xiang,Xianrui Hui,Lijun Yang,Ru Lin,Weize Xu,Qiang Shu

DOI: https://doi.org/10.1016/j.scr.2024.103616

IF: 1.587

2024-01-01

Stem Cell Research

Abstract:The leucine zipper-like transcriptional regulator 1 (LZTR1) gene has been reported to be associated with many kinds of human diseases, including cardiac disease, Noonan syndrome, and schwannomatosis. In this study, peripheral blood mononuclear cells (PBMCs) derived from patient diagnosed with dilated cardiomyopathy (DCM) was successfully reprogrammed into the human induced pluripotent stem cells (iPSCs) line, harboring a distinct heterozygous mutation in the LZTR1 gene. The established patient-derived iPSCs expressed endogenous pluripotent markers, demonstrated the potential to differentiate into three germ layers (endoderm, mesoderm, and ectoderm), and exhibited a normal karyotype.
Generation of 3 patient induced Pluripotent stem cell lines containing SORD mutations linked to a recessive neuropathy

Christopher Yanick,Renata Maciel,Elizabeth Jacobs,Jacquelyn Schatzman,Michael Shy,Stephan Zuchner,Mario Saporta

DOI: https://doi.org/10.1016/j.scr.2024.103449

Abstract:The SORD neuropathy has been identified as the most common autosomal recessive inherited neuropathy, occurring in thousands of patients worldwide. Fibroblast lines from 3 different patients containing the c.753delG; p.Ala253GlnfsTer27 SORD mutations were reprogrammed into induced Pluripotent Stem Cell (iPSC) lines. These iPSC lines demonstrate an apparent normal karyotype and have positive expression of pluripotency markers. These iPSC lines also stain positively for Ectoderm, Endoderm and Mesoderm markers following Embryoid body differentiation. These lines pose to serve as a valuable disease modeling resource for studying the SORD neuropathy, including studying disease phenotype and treatment efficacy.
Establishment of the induced pluripotent stem cell line SJTUGHi002-A from a CNGA1-related recessive retinitis pigmentosa patient

Yidong Wu,Ting Zhang,Zhixuan Chen,Lu Tang,Lei Zhang,Jieqiong Chen,Xiaoling Wan,Xiaodong Sun

DOI: https://doi.org/10.1016/j.scr.2024.103334

IF: 1.587

2024-04-01

Stem Cell Research

Abstract:Retinitis pigmentosa (RP) is the most common inherited retinal diseases, characterized by photoreceptor cell death and retinal pigment epithelial atrophy. Mutations in cyclic nucleotide gated channel subunit alpha 1 (CNGA1) have been reported to cause retinitis pigmentosa. Here, we established the human induced pluripotent stem cell line (iPSC) SJTUGHi002-A, generated from peripheral blood mononuclear cells of a 36-year-old male RP patient, who carried a homozygous frameshift variant in CNGA1 gene (c.265delC; p.L89Ffs*4). The cell line can serve as a patient-derived disease model for exploring the pathogenesis and drug development of CNGA1-RP.

cell biology,biotechnology & applied microbiology,cell & tissue engineering
Generation of induced Pluripotent Stem Cells (UNIBSi008-A, UNIBSi008-B, UNIBSi008-C) from an Ataxia-Telangiectasia (AT) patient carrying a novel homozygous deletion in ATM gene

S Masneri,R M Ferraro,G Lanzi,G Piovani,L Mori,C Barisani,D Moratto,A Plebani,R Badolato,A Soresina,S Giliani

DOI: https://doi.org/10.1016/j.scr.2019.101596

Abstract:Using a Sendai Virus based vector delivering Yamanaka Factors, we generated induced Pluripotent Stem Cells (iPSCs) from peripheral blood mononuclear cells of a patient affected by Ataxia Telangiectasia (AT), caused by a novel homozygous deletion in ATM, spanning exons 5-7. Three clones were fully characterized for pluripotency and capability to differentiate. These clones preserved the causative mutation of parental cells and genomic stability over time (>100 passages). Furthermore, in AT derived iPSCs we confirmed the impaired DNA damage response after ionizing radiation. All these data underline potential usefulness of our clones as in vitro AT disease model.
Generation of iPSC line (FMCPGHi003-A) from human PBMCs of a patient with Familial hemiplegic migraine type 3

Tao Wang,Yanan Li,Chunxiao Yang,Huijuan Yuan,Weinan Na,Shengyuan Yu

DOI: https://doi.org/10.1016/j.scr.2024.103465

Abstract:Peripheral blood mononuclear cells (PBMCs) were obtained from a patient diagnosed with Familial Hemiplegic Migraine Type 3, who carried a heterozygous A > C mutation in the SCN1A gene and reprogrammed using CytoTuneTM-iPS 2.0 Sendai Reprogramming Kit. The iPSC line maintained the mutation while expressing markers of pluripotency. Additionally, it exhibited a normal karyotype and demonstrated potential for in vitro differentiation into cells representing all three embryonic germ layers.
Establishing a human-induced pluripotent stem cell line (SMUSHi003-A) from a patient with Charcot-Marie-Tooth disease and focal segmental glomerulosclerosis

Qunjuan Lei,Wenyan Zhou,Ling Huang,Yu Zhang,Xueqing Xu,Xiaohua Guo

DOI: https://doi.org/10.1016/j.scr.2024.103357

IF: 1.587

2024-02-25

Stem Cell Research

Abstract:INF2 mutations cause Charcot-Marie-Tooth disease (CMT), and /or focal segmental glomerulosclerosis (FSGS) in an autosomal dominant inheritance mode, whose underlying mechanism remains unclear. Here, we report the generation of an iPSC line from a female patient with CMT and FSGS. The iPSC line from the patient's PBMCs carried a heterozygous INF2 deletion mutation (c.315_323delGCGCGCCGT) within the conserved E2. This line exhibited a normal karyotype, high expression of pluripotency markers, and trilineage differentiation potential. This line can be used to dissect the complex pathomechanism through further induction of differentiation into related cells and as a drug screening tool for INF2-associated diseases.

cell biology,biotechnology & applied microbiology,cell & tissue engineering
Generation of the Human Induced Pluripotent Stem Cell Line (Zjui005-A) from a Patient with Pelizaeus-Merzbacher Disease (PMD) Carrying a Novel Hemizygous Mutation in PLP1 Gene

Bei Liu,Lang Chen,Jian Sun,Li Zhang,Min Chen,Yeqing Qian,Yanlin Wang,Kai Yan,Linxiao Hou,Yingzhi Huang,Dan Zhang,Yuming Xu,Jialing Yu,Jin Zhang,Minyue Dong

DOI: https://doi.org/10.1016/j.scr.2020.101791

IF: 1.587

2020-01-01

Stem Cell Research

Abstract:Pelizaeus-Merzbacher disease (PMD) is a rare X-linked leukodystrophy caused by mutations in the proteolipid protein 1 gene (PLP1) which is specifically expressed on the myelin sheath of oligodendrocytes. We established an induced pluripotent stem cell (iPSC) line (ZJUi005-A) from peripheral blood mononuclear cells of an 18-year-old male PMD patient with a novel hemizygous c.437T>C mutation in PLP1 gene using episomal reprogramming plasmids. The ZJUi005-A iPSC line carried the PLP1 mutation, expressed pluripotency markers, exhibited normal karyotype and showed differentiation potential in vitro.
Generation of an iPSC line (ZZUNEUi021-A) from a hypertrophic cardiomyopathy patient with TNNT2 mutation

Yiming Dong,Xiaowei Li,Wanrong Fu,Xiaoxu Tian,Guangli Guo,Ying Peng,Yafei Zhai,Jiangtao Zhao,Zhongren Ding,Xiaoyan Zhao,Jianzeng Dong

DOI: https://doi.org/10.1016/j.scr.2021.102622

IF: 1.587

2022-01-01

Stem Cell Research

Abstract:A 25-years-old hypertrophic cardiomyopathy male patient donated his peripheral blood mononuclear cells (PBMCs) with heterozygote mutation in theTNNT2 gene. We generated induced pluripotent stem cell (iPSC) with normal karyotypic and expressing NANOG, Lin28, GDF3 and DNMT3. The iPSC line has demonstrated pluripotency by differentiating into three germ layers in vitro. The ZZUNEUi021-A would serve as an in vitro model for loss of TNNT2 function.
Generation of IGGi003-A induced pluripotent stem cell line from a patient with Sotos Syndrome carrying c.1633delA NSD1 variant in exon 5

Giuseppina Conteduca,Chiara Baldo,Alessia Arado,Joana Soraia Martinheira da Silva,Barbara Testa,Simona Baldassari,Federico Zara,Gilberto Filaci,Domenico Coviello,Michela Malacarne

DOI: https://doi.org/10.1016/j.scr.2024.103324

IF: 1.587

2024-01-31

Stem Cell Research

Abstract:Sotos syndrome (SoS) is a neurodevelopmental disorder that results from NSD1 mutations that cause haploinsufficiency of NSD1. Here, we generated an induced pluripotent stem cell (iPSC) line from fibroblasts of a SoS patient carrying the pathogenic variant (c.1633delA). The cell line shows typical iPSC morphology, high expression of pluripotent markers, normal karyotype, and it differentiates into three germ layers in vitro. This line is a valuable resource for studying pathological pathways involved in SoS.

cell biology,biotechnology & applied microbiology,cell & tissue engineering

Generation of an induced pluripotent stem cell line (SJTUGHi003-A) from a patient with Sorsby fundus dystrophy carrying c.484G>A mutation in TIMP3 gene

Establishment of an Induced Pluripotent Stem Cell Line (Zjulli004-A) from a Hypertrophic Cardiomyopathy Patient Carrying MYBPC3/c.3764C>A Mutation

Generation of an induced pluripotent stem cell line from a patient carrying FBN1/c.6734 G > A mutation

Generation of an induced pluripotent stem cell line from a patient carrying FBN1/c.6734 G > A mutation.

Generation of an Induced Pluripotent Stem Cell Line (Zjulli003-A) from a Hypertrophic Cardiomyopathy Patient Carrying MYH7/c.4384G > A Mutation

Generation of an Induced Pluripotent Stem Cell Line from a Brugada Syndrome Patient Carrying SCN5A/c.3118G>C Mutation

Generation of Induced Pluripotent Stem Cell Line (Zzui0012-A) from a Patient with Fahr's Disease Caused by a Novel Mutation in SLC20A2 Gene.

Generation of Induced Pluripotent Stem Cell Line (Zzui007-A) from a 52-Year-old Patient with a Novel CHCHD2 Gene Mutation in Parkinson's Disease.

Generation of an induced pluripotent stem cell line (ZJUi013-A) from a Familial cortical myoclonic tremor with epilepsy type 1 patient carrying (TTTCA)n insertion in the SAMD12 gene

Generation of Five Induced Pluripotent Stem Cell Lines with DMD/c.497G &gt; T Mutation from Renal Epithelial Cells of a Duchenne Muscular Dystrophy Patient and a Recessive Carrier Parent

Verification of an Ipsc Line (Lzui002-A) from a Patient with a Novel Mutation in the TBL1X Gene.

Generation of an induced pluripotent stem cell line (SJTUGHi001-A) from a patient with Retinitis Pigmentosa carrying c.77C > T mutation in RAX2 gene

Generation of a Human Induced Pluripotent Stem Cell Line from a Female Patient Carrying LZTR1 Gene Mutation

Generation of 3 patient induced Pluripotent stem cell lines containing SORD mutations linked to a recessive neuropathy

Establishment of the induced pluripotent stem cell line SJTUGHi002-A from a CNGA1-related recessive retinitis pigmentosa patient

Generation of induced Pluripotent Stem Cells (UNIBSi008-A, UNIBSi008-B, UNIBSi008-C) from an Ataxia-Telangiectasia (AT) patient carrying a novel homozygous deletion in ATM gene

Generation of iPSC line (FMCPGHi003-A) from human PBMCs of a patient with Familial hemiplegic migraine type 3

Establishing a human-induced pluripotent stem cell line (SMUSHi003-A) from a patient with Charcot-Marie-Tooth disease and focal segmental glomerulosclerosis

Generation of the Human Induced Pluripotent Stem Cell Line (Zjui005-A) from a Patient with Pelizaeus-Merzbacher Disease (PMD) Carrying a Novel Hemizygous Mutation in PLP1 Gene

Generation of an iPSC line (ZZUNEUi021-A) from a hypertrophic cardiomyopathy patient with TNNT2 mutation

Generation of IGGi003-A induced pluripotent stem cell line from a patient with Sotos Syndrome carrying c.1633delA NSD1 variant in exon 5

Generation of Five Induced Pluripotent Stem Cell Lines with DMD/c.497G > T Mutation from Renal Epithelial Cells of a Duchenne Muscular Dystrophy Patient and a Recessive Carrier Parent